Superworth

Cencora forward PE COR

Share price divided by analysts' consensus earnings for the next twelve months, since 2008.

Today, Oct 23, 2026
17.0×
10-year median
13.9×
Against its 10-year history
87th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.5× to 20.7×
Peer median
20.7×

Cencora's forward PE is 17.0× as of Oct 23, 2026.

That is above its ten-year median of 13.9×, higher than on 87% of days in the last ten years.

Over that time it ranged from 10.5× in Mar 2020 to 20.7× in Nov 2025.

The median for 3 medical distribution stocks of a similar size is 20.7×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far17.0×13.7×20.3×
202519.2×15.0×20.7×
202414.9×14.9×17.8×
202315.8×12.7×15.8×
202214.3×11.9×15.5×
202112.5×10.7×12.9×
202011.1×10.5×13.3×
201911.5×10.6×12.7×
201811.1×10.8×17.4×
201715.1×12.3×16.3×
201613.9×12.5×18.4×
201519.5×17.6×24.3×
201420.5×15.3×20.6×
201318.7×14.3×18.9×
201214.1×12.3×16.4×
201115.2×14.7×53.7×
201043.0×13.2×45.9×
200913.2×9.0×13.3×
200810.8×9.4×14.1×

Against its peers

Companies in Medical - Distribution nearest Cencora's size, closest first, today.

CompanyForward PE
CORCencora17.0×
CAHCardinal Health19.9×
MCKMcKesson21.6×
HSICHenry Scheinn/m
Peer median20.7×

Where Cencora ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Cencora

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.